Pillar5 Pharma

Arnprior, Canada Founded: 2009 • Age: 17 yrs Acquired By Anjac
Solid dose and sterile ophthalmic products are contract-manufactured.

About Pillar5 Pharma

Pillar5 Pharma is a Healthcare company based in Arnprior (Canada) founded in 2009, and was acquired by Anjac in March 2022. Solid dose and sterile ophthalmic products are contract-manufactured. Its chief executive, as recorded, is Dwight Gorham Gorham. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.

Company details

Pillar5 Pharma was founded in 2009 and is based in Arnprior, Canada. Contract manufacturing services are provided in the pharmaceutical sector, with a focus on solid dose and sterile ophthalmic products. Capabilities include multi-dose preservative-free formulations, method development, analytical and microbiology testing, technical transfer, scale-up processes, and registration or pilot-scale production. Operations support various stages of drug development and manufacturing.

  • Headquarters Arnprior, Canada
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pillar5pharma.com
  • Social LinkedIn
  • Acquired by Anjac (Mar 2022)
Key Metrics

Investors in Pillar5 Pharma

Pillar5 Pharma has secured backing from 1 investor. Prominent investors backing the company include Anjac.

All
InvestorDescriptionFounded YearDomainLocation
Develops health and beauty innovations via manufacturing and global partnerships.
2008anjac.comParis, France
Premium access

Investor details for Pillar5 Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pillar5 Pharma

1 people are tracked at Pillar5 Pharma (1 in leadership).

NameRoleGroup
Dwight Gorham Gorham
CEO & PresidentLeadership
Premium access

Complete people profiles for Pillar5 Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Pillar5 Pharma

2 dated milestones of Pillar5 Pharma across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pillar5 Pharma is founded.
  2. Exit Acquired by Anjac.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pillar5 Pharma

Pillar5 Pharma was founded in 2009.

Pillar5 Pharma is headquartered in Arnprior, Canada. It is registered at Arnprior, Ontario, Canada.

Dwight Gorham Gorham is the CEO of Pillar5 Pharma, as recorded in our data.

Pillar5 Pharma was founded in 2009 and is based in Arnprior, Canada. Contract manufacturing services are provided in the pharmaceutical sector, with a focus on solid dose and sterile ophthalmic products. Capabilities include multi-dose preservative-free formulations, method development, analytical and microbiology testing, technical transfer, scale-up processes, and registration or pilot-scale production. Operations support various stages of drug development and manufacturing.

Pillar5 Pharma has 1 investor. Key investors include Anjac.

Yes. Pillar5 Pharma was acquired by Anjac in March 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available